Skip to main content

First Zantac Trial Scheduled For October 2022

First Zantac Trial Scheduled For October 2022

First Zantac Trial Scheduled For October 2022

Introduction

The first Zantac cancer lawsuit will go for a trial before the jury in October 2022, which will decide the fate of similar claims in future as indicated by a jury in California state court.

As per the court documents, plaintiffs accuse that Boehringer Ingelheim, GlaxoSmithKline, Sanofi and other drug distributors, retailers and manufacturers were aware of the risks associated with Zantac, yet they marketed it as safe in the drug market.

All the Zantac cases are consolidated before a state judge under Judicial Council Coordinated Proceedings (JCCP) for coordinated discovery. Currently, more than 70,000 product liability claims have been filed by former Zantac users with similar allegations that it converts into human carcinogen after storage or passed through the human body.

California Superior Court Judge Evelio Grillo is overseeing the Zantac JCCP in Alameda County that will begin on October 10, 2022. The second case is likely to begin in 2023.

The outcome of these trials would not affect other plaintiffs but will have a huge impact on future litigations. Ranitidine hydrochloride, sold under the name of Zantac in the U.S. market, is used to prevent and treat the ulcers formed in the stomach and intestine.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!